The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease.

Autor: Stadler M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany. stadler.michael@mh-hannover.de., Hambach L; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany., Dammann E; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany., Diedrich H; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany., Kamal H; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany., Hamwi I; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany., Schultze-Florey C; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany., Varvenne M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany., Ehrlich S; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany., Buchholz S; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany., Koenecke C; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany., Beutel G; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany., Weissinger EM; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany., Krauter J; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany., Eder M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany., Hertenstein B; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany., Ganser A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1 , D - 30625, Hannover, Germany.

Publikováno v: Annals of hematology [Ann Hematol] 2023 Sep; Vol. 102 (9), pp. 2529-2542. Date of Electronic Publication: 2023 Jul 25.

Konzeption und Entwicklung eines Data-Warehouse-basierenden Werkzeugs zur Analyse und Auswertung von Forschungsdaten zur akuten myeloischen Leukämie unter Einbeziehung semantischer Bezugssysteme

Autor: Ruppel, J, Gerbel, S, Hamwi, I, Heuser, M, Bott, OJ

Publikováno v: 63. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS); 20180902-20180906; Osnabrück; DOCAbstr. 188 /20180827/

Einleitung: Bei der akuten myeloischen Leukämie (AML) handelt es sich um eine maligne Erkrankung, der eine gestörte Hämatopoese zugrunde liegt. Insgesamt ist die AML eine seltene (ORPHA: 519, ICD-10: C92.0) und meist erst im höheren Alter auftret

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c04884eb7caab28aab7e098028856b9

Klinische Einflussfaktoren auf die Rotationsfehlstellung bei Femurmarknagelung

Autor: Hüfner, T, Citak, M, Kendoff, D, Hamwi, I, von Falck, C, Krettek, C

Publikováno v: Deutscher Kongress für Orthopädie und Unfallchirurgie; 71. Jahrestagung der Deutschen Gesellschaft für Unfallchirurgie, 93. Tagung der Deutschen Gesellschaft für Orthopädie und Orthopädische Chirurgie, 48. Tagung des Berufsverbandes der Fachärzte für Orthopädie; 20071024-20071027; Berlin; DOCW72-1567 /20071009/

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1175::19c1bf63201a17a0bf326e04c1678ec8
http://www.egms.de/en/meetings/dkou2007/07dkou748.shtml

Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.

Autor: Thol F; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Gabdoulline R; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Liebich A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Klement P; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Schiller J; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Kandziora C; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Hambach L; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Stadler M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Koenecke C; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Flintrop M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Pankratz M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Wichmann M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Neziri B; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Büttner K; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Heida B; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Klesse S; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Chaturvedi A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Kloos A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Göhring G; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Schlegelberger B; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Gaidzik VI; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Bullinger L; Department of Internal Medicine III, University of Ulm, Ulm, Germany.; Department of Hematology, Oncology and Tumorimmunology, Charité University Medicine, Berlin, Germany., Fiedler W; Department of Medicine II, Oncological Center, Hubertus Wald University Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Heim A; Department of Virology, Hannover Medical School, Hannover, Germany., Hamwi I; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Eder M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Krauter J; Department of Hematology and Oncology, Klinikum Braunschweig, Braunschweig, Germany; and., Schlenk RF; Nationales Centrum für Tumorerkrankungen Heidelberg, Heidelberg, Germany., Paschka P; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Döhner K; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Döhner H; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Ganser A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and., Heuser M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation and.

Publikováno v: Blood [Blood] 2018 Oct 18; Vol. 132 (16), pp. 1703-1713. Date of Electronic Publication: 2018 Sep 06.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.